Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| University of California, Los Angeles, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| University of California, Los Angeles, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| University of California, Los Angeles, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| University of California, Los Angeles, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 1 |
| University of California, Los Angeles, Medical Devices Deals, 2010 to YTD 2016 | 9 | 1 |
| University of California, Los Angeles, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 10 | 2 |
| University of California, Los Angeles, Pharmaceuticals &Healthcare, Deal Details | 12 | 19 |
| Partnerships | 12 | 1 |
| InvVax Receives Rights to Vaccine Technology from University of California, Los Angeles | 12 | 1 |
| Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies | 13 | 2 |
| Trethera Enters into Research Agreement with University of California, Los Angeles | 15 | 1 |
| Bristol-Myers Squibb Enters into Research Agreement with UCLA | 16 | 1 |
| BioNano Genomics Enters into Research Agreement with University of California, Los Angeles | 17 | 1 |
| Zymeworks Enters into Research Agreement with University of California, Los Angeles | 18 | 1 |
| NanoSmart Pharma Enters Into Research Agreement With UCLA For Pediatric Cancer Drug Development | 19 | 1 |
| UCLA Medical Center Forms Joint Venture With First Affiliated Hospital Of Medical School | 20 | 1 |
| Prometheus Labs Enters Into Research Agreement With University Of California | 21 | 1 |
| Licensing Agreements | 22 | 1 |
| Klyss Biotech Receives Rights to Antibody from University of California, Los Angeles | 22 | 1 |
| Fibrocell Science Enters into Licensing Agreement with University of California to Advance the Development of Personalized Cell Therapies | 23 | 1 |
| Max Biopharma Enters Into License Agreement With UCLA And Johns Hopkins University For Small Molecule Technology | 24 | 1 |
| Diamyd Medical Expands Licensing Agreement with University Of California, Los Angeles | 25 | 1 |
| BioTime Enters Into Licensing Agreement With University of California, Los Angeles | 26 | 1 |
| Quest PharmaTech Enters Into Licensing Agreement With University Of California At Los Angeles For Cancer Treatment | 27 | 1 |
| Fibrocell Science Enters Into Licensing Agreement With University of California | 28 | 1 |
| Asset Transactions | 29 | 1 |
| Royalty Pharma Acquires Royalty Rights of Xtandi from University of California, Los Angeles for USD1.14 Billion | 29 | 2 |
| University of California, Los Angeles - Key Competitors | 31 | 1 |
| Key Employees | 32 | 1 |
| Locations And Subsidiaries | 33 | 3 |
| Head Office | 33 | 1 |
| Other Locations &Subsidiaries | 33 | 3 |
| Appendix | 36 | 1 |
| Methodology | 36 | 1 |
| About GlobalData | 36 | 1 |
| Contact Us | 36 | 1 |
| Disclaimer | 36 | 1 |